MedTrace Logo

Effect of Magnesium Supplementation for Children With Drug Resistant Idiopathic Epilepsy

NCT02982824 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2017-05-09

No results posted yet for this study

Summary

Effect of oral magnesium sulfate (Mg) supplementation will be studied. Children with drug resistant idiopathic epilepsy following up in Pediatric Neurology Clinic, Ain Shams University, will be randomized to either Mg add-on treatment group or anti-epileptic drugs AEDs alone. Serum magnesium, seizure control and Intelligent quotation (IQ) will be done at base line and after 6 months of treatment.

Conditions

  • Drug Resistant Epilepsy

Interventions

DIETARY_SUPPLEMENT

Magnesium

Oral magnesium

DRUG

Placebo - Concentrate

Placebo will be given

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Sahar MA Hassanein, PhD. MD · Pediatrics, Faculty of Medicine, Ain Shams University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2017-02-28
Completion
2017-03-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02982824 on ClinicalTrials.gov